期刊文献+

HPLC法测定盐酸伊伐布雷定片的含量 被引量:1

Determination of Ivabradine Hydrochloride Tablets by HPLC
下载PDF
导出
摘要 目的建立高效液相色谱法测定盐酸伊伐布雷定片含量的方法。方法采用Thermo ODS Hypersil色谱柱(4.6 mm×250 mm,5μm),流动相为0.5%甲酸溶液(用氨水调节pH值至6.5)-乙腈(68∶32),流速为1.0 mL.min-1,检测波长为286 nm。结果伊伐布雷定在119.98~279.95μg.mL-1的浓度范围内线性关系良好(r=0.999 9),平均回收率为99.92%,RSD为0.09%。结论本方法简便、快速、准确,可用于盐酸伊伐布雷定片的质量控制。 Objective To establish an HPLC method for the determination of Ivabradine Hydrochloride Tablets. Methods Thermo ODS Hypersil column(4.6 mm ×250mm,5μm) was adopted with 0.5% formic acid( adjusted pH 6.5 by ammonia) - acetonitrile ( 68:32 ) as mobile phase, the flow rate was 1.0 mL·mim^-1 and the detection wavelength was 286 nm. Results The ivabradine showed a good linear relationship within the range of 119.98 -279.95μg·mL^-1 ( r = 0. 999 9 }, the average recovery was 99.92% and the RSD was 0.09%. Conclusion The method was convenient, rapid and accurate, and it can be used for the quality control of Ivabradine Hydrochloride Tablets.
出处 《齐鲁药事》 2012年第5期275-276,共2页 qilu pharmaceutical affairs
关键词 高效液相色谱法 盐酸伊伐布雷定片 含量测定 HPLC Ivabradine Hydrochloride Tablets Determination
  • 相关文献

参考文献3

二级参考文献23

  • 1TARDIF JC. Clinical efficacy of ivabradine[ J]. Heart Drug, 2005, 5(1): 25 -28.
  • 2NABEL EG, SELWYN AP, GANZ P. Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate [J]. Circulation, 1990, 81(3): 850-859.
  • 3VATNER SF, BAIG H. Importance of heart rate in determining the effects of sympathomimetic amines on regional myocardial function and blood flow in conscious dogs with acute myocardial ischemia[J]. Circ Res, 1979, 45(6): 793 -803.
  • 4ROBERTO F, ANNA C, CLAUDIO C. Anti-ischaemic effect of ivabradine[J]. Pharm Res, 2006, 53(5): 435 -439.
  • 5BROWN HF, DIFRANCESCO D, NOBLE SJ. How does adrenaline accelerate the heart? [ J]. Nature, 1979, 280 (5719) : 235 -236.
  • 6DIFRANCESCO D. Characterization of singte pacemaker channels in cardiac sino-atrial node cells [ J]. Nature, 1986, 324 ( 6096 ) :470 - 473.
  • 7DIFRANCESCO D. The contribution of the "pacemaker" current (If) to generation of spontaneous activity in rabbit sino-atrial node myocytes[J].J Physiol, 1991, 434 (1) :23 - 40.
  • 8European Public Assessment Report (EPAR): Scientific discussion for Procoralan. London : EMEA, 2005 [ EB/OL ]. [ 2007 -11- 16]. http ://www. emea. eu. int.
  • 9BORER JS, FOX K, JAILLON P, et al. Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial [ J ]. Circulation, 2003, 107 ( 6 ) : 817 - 823.
  • 10LOPEZ-BESCOS L, FILIPOVA S, MARTOS R. Long term safety and anti-anginal efficacy of the If current inhibitor ivabradine in patients with chronic stable angina. A one-year randomised, double blind multicentre trial[ J ]. Eur Heart J, 2004, (Abstract Suppl. ) :138[A876].

共引文献28

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部